MILO SENSORS, INC.

SANTA BARBARA, CA · Founded 2016 · Medtech · Private

Transdermal wearable biosensor for continuous non-invasive measurement of blood alcohol concentration

Claim this profile

Follows are private to you and power your alerts

Updated · milo.io

Sector
Medtech
Headquarters
SANTA BARBARA, CA
Founded
2016
Latest Form D
$700K, Nov 2017
Total capital
$3.1M
Federal grants
$2.3M
3 awards · 2017–2020
Rank in peer group#496 of 538
Private capital raised
$763K
2 Form D · last Nov 2017
108 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
2
6 pending · first 2018
Rank in peer group#190 of 538

Capital timeline

20162017201820192020FEDERAL ↑EQUITY ↓Cumulative $3.1M$224K$1M$1M1st Form D$63K2nd Form D$700K
20162017201820192020FEDERAL ↑EQUITY ↓Cumulative $3.1M$224K$1M$1M1st Form D$63K2nd Form D$700K

Latest events

  • Federal grantHealth and Human S · Phase II · Enzymatic transdermal alcohol biosensor$1M
  • Federal grantHealth and Human S · Phase II · Enzymatic transdermal alcohol biosensor$1M
  • Private capital raisedForm D · SEC · 2nd filing$700K
  • Federal grantHealth and Human S · Phase I · Disposable cartridge transdermal ethanol sensors$224K
  • Private capital raisedForm D · SEC · 1st filing$63K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 538 peers

Line = median

Medtech · Device

  • Federal grantsBelow median
  • Granted patents#190 · top 35%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants
  • Bob R. LansdorpResearcherDirectorLinked by 2 patents
  • Evan R. StrenkExecutive Officer, DirectorNamed in SEC Form D filings

What it has protected

USPTO · 2 granted of 8
  • PendingA gel-based matrix for extending biocatalyst turnover lifetimeUSPTOApplication 18398794
  • PendingSystem For Slow Release Of EnzymesUSPTOApplication 17301440
  • PendingSkin Proximity Sensor for Tamper DetectionUSPTOApplication 17301395
Show all 8 patent records
  • A gel-based matrix for extending biocatalyst turnover lifetimeJul 4, 2024 · Application 18398794Pending
  • System For Slow Release Of EnzymesOct 7, 2021 · Application 17301440Pending
  • Skin Proximity Sensor for Tamper DetectionOct 7, 2021 · Application 17301395Pending
  • Transdermal Analyte Sensing DeviceSep 29, 2020 · US 10,786,189Granted
  • Device And Method For User-actuated Mixing Of Dry Reagent With LiquidSep 5, 2019 · Application 15968994Pending
  • Transdermal Analyte Sensing DeviceJan 2, 2018 · US 9,855,000Granted
  • A gel-based matrix for extending biocatalyst turnover lifetimeApplication 63477465Pending
  • Transdermal Analyte Sensing DeviceApplication PCTUS2016033105Pending

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .